HER-2, EGFR, COX-2 Expression status correlated to microvessel density and survival in resected non-small cell lung cancer

Author： Brattström Daniel   Wester Kenneth   Bergqvist Michael   Hesselius Patrik   Malmström Per-Uno   Nordgren Hans   Wagenius Gunnar   Brodin Ola  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.43, Iss.1, 2004-03, pp. : 80-86

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EGFR inhibitors in non-small cell lung cancer (NSCLC): the emerging role of the dual irreversible EGFR/HER2 inhibitor BIBW 2992

By Spicer James  

Targeted Oncology, Vol. 5, Iss. 4, 2010-12 ,pp. : 245-255

Springer Publishing Company

Access to resources Recommend Favorite

Hepatocyte growth factor and HER2/neu downregulate expression of apoptosis-inducing factor in non-small cell lung cancer

By          

Oncology Reports, Vol. 31, Iss. 2, 2014-01 ,pp. : 597-604

Spandidos Publications

Access to resources Recommend Favorite

Surveillance of resected non-small cell lung cancer

By López-González A.  

Clinical and Translational Oncology, Vol. 14, Iss. 10, 2012-10 ,pp. : 721-725

Springer Publishing Company

Access to resources Recommend Favorite

Expression and association of HER2 with prognosis in early-stage (T1-T2N0M0) non-small cell lung cancer

By Xia Qing  

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1719-1725

Springer Publishing Company

Access to resources Recommend Favorite

Lack of prognostic value of EGFR mutations in primary resected non-small cell lung cancer

By Lim Ken-Hong   Huang Ming-Jer   Liu Hung-Chang   Kuo Hsu-Tah   Tzen Chin-Yuan   Hsieh Ruey-Kuen  

Medical Oncology, Vol. 24, Iss. 4, 2007-12 ,pp. : 388-393

Humana Press, Inc

Access to resources Recommend Favorite